Dynamics of coregulator-induced conformational perturbations in androgen receptor ligand binding domain

Mikhail N Zakharov1, Biju K Pillai, Shalender Bhasin

  • 1Section of Endocrinology, Boston University School of Medicine, 670 Albany St., Boston, MA 02118, USA.

Insights

Androgen receptor (AR) coregulators induce distinct AR-LBD conformations, influencing gene expression. This coactivator-specific conformational gating dictates downstream interactions and DNA binding affinity.

Area of Science:

  • Molecular biology
  • Biochemistry
  • Structural biology

Background:

  • Androgen receptor (AR) coregulators are crucial for modulating ligand-induced gene expression.
  • The precise molecular mechanisms governing AR coregulator function and sequence-specific effects remain incompletely understood.

Purpose of the Study:

  • To investigate the molecular events following coactivator binding to the AR ligand-binding domain (AR-LBD).
  • To elucidate the mechanisms by which AR coregulators induce sequence-specific effects on AR conformation and function.

Main Methods:

  • Utilized consensus coactivator sequences (D11-FxxLF) and biophysical techniques to study AR-LBD conformational changes.
  • Employed computational modeling to analyze coactivator-induced alterations in AR-LBD backbone flexibility.
  • Characterized specific coactivator consensus sequences (ARA70 and SRC3-1).

Main Results:

  • Coactivator association triggers an enthalpically and entropically favorable conformational rearrangement in the AR-LBD, with an activation energy of 29.8±4.2 kJ/mol.
  • Distinct coactivators (ARA70, SRC3-1) induce unique conformational states in the dihydrotestosterone:AR-LBD:coactivator complex.
  • Computational modeling revealed coactivator-specific alterations in AR-LBD backbone flexibility, distant from the binding site.

Conclusions:

  • Coactivators may confer specificity to the transcriptional machinery by altering the steady-state conformation of the AR-LBD.
  • AR-LBD can adopt distinct conformational states even with the same ligand, dependent on specific coactivator interactions within tissues.
  • Coactivator-specific conformational gating likely dictates subsequent binding partners and DNA-response element interaction affinity.

Related Concept Videos

Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...